| Study Periods for Medicaid Data Abstraction (in months) | |||
---|---|---|---|---|
Pre-Implementation (-12 randomization (-1)) | Implementation Year 1 (1–12) | Implementation Year 2 (13–24) | Post-Implementation (25–36*) | |
MEASURES OF PRIMARY AND SECONDARY OUTCOMES | ||||
MOUDa engagement 34 days post-discharge | X | X | X | X |
EDb visits or acute hospitalizations within 30 days post-discharge (OUDc related or not) | X | X | X | X |
Discharges against medical advice during index hospitalization | X | X | X | X |
MEASURES OF EXPLORATORY OUTCOMES AND OTHER ASSESSMENTS | ||||
Hospitalization Diagnoses (at every discharge and ED visit) | X | X | X | X |
Medical Comorbidity | X | X | X | X |
Non-Fatal Overdose | X | X | X | X |
All-cause mortality (Medicaid data enrollment files) including time to death | X | X | X | X |
Time to re-admission (ED or acute care) post- discharge | X | X | X | X |
Discharges against medical advice during subsequent hospital visits | X | X | X | X |
MOUD initiation | X | X | X | X |
Opioid use disorder treatment initiation | X | X | X | X |
Pre-hospitalization MOUD within 60, 30, 14 or 0 days before admission | X | X | X | X |